Natural history, treatment (tx) patterns, and outcomes in MET dysregulated non-small cell lung cancer (NSCLC) patients (pts)

被引:0
|
作者
Wolf, J. [1 ]
Baik, C. [2 ]
Heist, R. S. [3 ]
Neal, J. W. [4 ]
Mansfield, A. S. [5 ]
Buettner, R. [6 ]
Davis, K. L. [7 ]
Giovannini, M. [8 ]
Mutebi, A. [9 ]
Awad, M. M. [10 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Washington, Thorac Head & Neck Med Oncol, Seattle, WA 98195 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
[5] Mayo Clin, Med Oncol, Rochester, MN USA
[6] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[7] RTI Hlth Solut, Hlth Econ, Res Triangle Pk, NC USA
[8] Novartis Pharmaceut, Global Clin Dev, E Hanover, NJ USA
[9] Novartis Pharmaceut, US Hlth Econ & Outcomes Res, E Hanover, NJ USA
[10] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
403 (PB-06
引用
收藏
页码:E131 / E131
页数:1
相关论文
共 50 条
  • [31] Impact of age on outcomes with PD-(L)1 blockade in patients (Pts) with non-small cell lung cancer (NSCLC).
    Lichtenstein, Morgan
    Nipp, Ryan David
    Goodwin, Kelly
    Anderson, Danyon
    Newcomb, Richard
    Gainor, Justin F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [33] Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and MET Exon 14 Skipping Mutations
    Kolaei, F. A. Zadeh Vosta
    Cai, B.
    Kanakamedala, H.
    Kim, J.
    Doban, V.
    Zhang, S.
    Shi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S16 - S16
  • [34] Treatment (tx) patterns and outcomes in resectable early-stage non-small cell lung cancer (NSCLC): A global real-world (rw) study
    Lin, S.
    Kahangire, D.
    Nagar, S.
    Ahn, M-J.
    Affi, R.
    Agulnik, J.
    Shih, J-Y.
    Hochmair, M. J.
    Tufman, A.
    Debieuvre, D.
    Chow, J.
    Jimenez, M.
    Davis, K.
    Sandelin, M.
    Veluswamy, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S93 - S94
  • [35] Safety and efficacy of dostarlimab in patients (pts) with recurrent/advanced non-small cell lung cancer (NSCLC)
    Subramanian, J.
    Moreno, V.
    Bosch-Barrera, J.
    Pikiel, J.
    Kristeleit, R.
    Guo, W.
    Danaee, H.
    Im, E.
    Roda, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S886 - S887
  • [36] ALK FISH positivity and crizotinib efficacy in patients (pts) with non-small cell lung cancer (NSCLC).
    Soria, Jean-Charles
    Ho, Steffan N.
    Varella-Garcia, Marileila
    Iafrate, A. John
    Solomon, Benjamin J.
    Shaw, Alice T.
    Blackhall, Fiona Helen
    Mok, Tony
    Wu, Yi-Long
    Pestova, Ekaterina
    Siebert, Fred W.
    Wilner, Keith D.
    Polli, Anna
    Paolini, Jolanda
    Lanzalone, Silvana
    Green, Stephanie J.
    Camidge, D. Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Treatment patterns and outcomes for patients (pts) with anaplastic lymphoma kinase-positive (ALK plus ) advanced non-small cell lung cancer (NSCLC) in US clinical practice
    Krebs, M. G.
    Polito, L.
    Smoljanovic, V.
    Trinh, H.
    Crane, G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [38] Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) monotherapy in US clinical practice
    Frueh, M.
    Rahma, O. E.
    Pachynski, R. K.
    Mazieres, J.
    Goldschmidt, J., Jr.
    Ton, T. G. N.
    Mhatre, S. K.
    Chuo, C-Y.
    Martinalbo, J.
    Davies, J.
    Juergens, R.
    ANNALS OF ONCOLOGY, 2019, 30 : 65 - 65
  • [39] Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study
    Ekman, S.
    Planck, M.
    Sorensen, J. B.
    Horvat, P.
    Layton, D.
    Kim, J.
    Rosenlund, M.
    Juarez-Garcia, A.
    Daumont, M.
    Jacobs, H. C.
    Lacoin, L.
    Brustugun, O. T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study
    de Castro, J.
    Tagliaferri, P.
    de Lima, V. C. C.
    Ng, S.
    Thomas, M.
    Arunachalam, A.
    Cao, X.
    Kothari, S.
    Burke, T.
    Myeong, H.
    Grattan, A.
    Lee, D. H.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)